Urologic Neoplasms Clinical Trials

Completed

Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma

NCT00794950

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations: Mark P. Schoenberg, MD Baltimore, Maryland, United States

Alon Weizer, MD Ann Arbor, Michigan, United States

View Trial Details

Completed

Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers

NCT02648178

Conditions: Bladder Cancer, Cancer of Head and Neck, Chemically-Induced Disorders, +22 more
Locations: Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma

NCT03519542

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, A Coruña, Spain

Hospital Marqués de Valdecilla Santander, Cantabria, Spain

Hospital Universitario central de Asturias Oviedo, Principality of Asturias, Spain

Hospital Universitarios de Burgos Burgos, Spain

View Trial Details

Completed

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant

NCT01305200

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, +89 more
Locations: Children's Oncology Group Arcadia, California, United States

City of Hope Duarte, California, United States

Children's Hospital and Research Center at Oakland Oakland, California, United States

Rady Children's Hospital - San Diego San Diego, California, United States

View all 35 locations

View Trial Details

Completed

Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer

NCT02843607

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cancer Institute in Fuda cancer hospital Guangzhou, Guangdong, China

View Trial Details

Completed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00005799

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
Locations: City of Hope Medical Center Duarte, California, United States

Stanford University Hospitals and Clinics Stanford, California, United States

University of Colorado Denver, Colorado, United States

Baylor University Medical Center Dallas, Texas, United States

View Trial Details

Completed

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

NCT01282463

Conditions: Adenocarcinoma, Carcinoma, Carcinoma of Renal Pelvis, +21 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sacramento, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States

View all 32 locations

View Trial Details

Completed

Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

NCT02141490

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Pharmaco-Economic Study of Treatment Options in Patients With Advanced RCC

NCT03699579

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: National Taiwan University Hospital Taipei, Taiwan

Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Completed

A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors

NCT02999672

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +22 more
Locations: IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica Meldola, Emilia-Romagna, Italy

Irccs Ospedale San Raffaele;Oncologia Medica Milan, Lombardy, Italy

Irccs Istituto Europeo Di Oncologia (IEO); Cure Mediche Milan, Lombardy, Italy

IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima Padova, Veneto, Italy

View all 16 locations

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions